Efficacy and Safety of Risankizumab in the Treatment of Crohn's Disease of the Pouch

Nan Lan,Bo Shen
DOI: https://doi.org/10.14309/crj.0000000000001476
2024-08-29
Abstract:Risankizumab has shown efficacy in the treatment of moderate-to-severe Crohn's disease (CD). The use of risankizumab in the treatment of CD of the pouch has not been previously reported. Here, we have 10 patients with biologics exposed CD of the pouch treated with risankizumab. Some patients showed endoscopic improvement regarding inflammation with minimal clinical improvement. Our findings warrant further study to validate the efficacy and safety of risankizumab in the treatment of CD of the pouch.
What problem does this paper attempt to address?